China FDA Clears Agilent Technologies Microarray Scanner.
M2 PHARMA-January 27, 2015-China FDA Clears Agilent Technologies Microarray Scanner
(C)2015 M2 COMMUNICATIONS
The China Food and Drug Administration has approved US-based Agilent Technologies Inc.'s (NYSE: A) SureScan Dx microarray scanner as a medical device for in vitro diagnostic use.
The product is CE marked for in vitro diagnostic use in Europe. It is approved for in vitro diagnostic use in South Korea and Singapore.
According to Agilent, the SureScan Dx microarray scanner comes with an autoloader and Agilent Microarray Scan Control software. The system measures fluorescence signals from labeled DNA and RNA targets hybridized to microarrays, for example, to compare two DNA samples for differences.
Agilent Technologies provides instruments, software, services, and consumables for the entire laboratory workflow. Agilent generated revenues of USD 4.0bn in fiscal 2014. The company employs about 12,000 people worldwide.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 27, 2015|
|Previous Article:||Neovasc Launches Common Share Offering.|
|Next Article:||Molex Launches MediSpec Waveguide for Medical Lasers.|